Probatech was founded to make sure that new opportunities in the life sciences are explored to their full potential. We do this by bridging the early-stage innovation gap - by connecting pharma companies and investors with start-ups developing new drugs, vaccines or platform technologies. For our partners in pharma companies and VC firms, we source, curate and match them with the best opportunities for collaborations, licensing and acquisition globally. We're currently working with a portfolio of companies developing vaccines and therapeutics, predominantly in Europe and in the US. For founders of therapeutics and vaccines start-ups, we support them with communicating their value and getting connected to partners and investors. See www.probacure.com for more information.